[go: up one dir, main page]

WO2024050025A3 - A catheter for hydrodynamic injection - Google Patents

A catheter for hydrodynamic injection Download PDF

Info

Publication number
WO2024050025A3
WO2024050025A3 PCT/US2023/031726 US2023031726W WO2024050025A3 WO 2024050025 A3 WO2024050025 A3 WO 2024050025A3 US 2023031726 W US2023031726 W US 2023031726W WO 2024050025 A3 WO2024050025 A3 WO 2024050025A3
Authority
WO
WIPO (PCT)
Prior art keywords
hydrodynamic injection
catheter
present disclosure
disclosure relates
gene therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2023/031726
Other languages
French (fr)
Other versions
WO2024050025A2 (en
Inventor
Robert Kruse
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hydrogene Therapeutics Inc
Original Assignee
Hydrogene Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hydrogene Therapeutics Inc filed Critical Hydrogene Therapeutics Inc
Priority to EP23861304.6A priority Critical patent/EP4580736A2/en
Publication of WO2024050025A2 publication Critical patent/WO2024050025A2/en
Publication of WO2024050025A3 publication Critical patent/WO2024050025A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/0021—Catheters; Hollow probes characterised by the form of the tubing
    • A61M25/0023—Catheters; Hollow probes characterised by the form of the tubing by the form of the lumen, e.g. cross-section, variable diameter
    • A61M25/0026—Multi-lumen catheters with stationary elements
    • A61M25/0032—Multi-lumen catheters with stationary elements characterized by at least one unconventionally shaped lumen, e.g. polygons, ellipsoids, wedges or shapes comprising concave and convex parts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
    • A61B5/021—Measuring pressure in heart or blood vessels
    • A61B5/0215—Measuring pressure in heart or blood vessels by means inserted into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M2025/0001—Catheters; Hollow probes for pressure measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/0021—Catheters; Hollow probes characterised by the form of the tubing
    • A61M25/0023—Catheters; Hollow probes characterised by the form of the tubing by the form of the lumen, e.g. cross-section, variable diameter
    • A61M25/0026—Multi-lumen catheters with stationary elements
    • A61M2025/0037—Multi-lumen catheters with stationary elements characterized by lumina being arranged side-by-side
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/10—Balloon catheters
    • A61M2025/1043—Balloon catheters with special features or adapted for special applications
    • A61M2025/1052—Balloon catheters with special features or adapted for special applications for temporarily occluding a vessel for isolating a sector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Physics & Mathematics (AREA)
  • Geometry (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present disclosure relates to an apparatus and system for hydrodynamic injection for gene therapy. More particularly, the present disclosure relates to an apparatus and system for hydrodynamic injection of gene therapy therapeutic agents into large animals and humans.
PCT/US2023/031726 2022-08-31 2023-08-31 A catheter for hydrodynamic injection Ceased WO2024050025A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP23861304.6A EP4580736A2 (en) 2022-08-31 2023-08-31 A catheter for hydrodynamic injection

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202263374237P 2022-08-31 2022-08-31
US63/374,237 2022-08-31

Publications (2)

Publication Number Publication Date
WO2024050025A2 WO2024050025A2 (en) 2024-03-07
WO2024050025A3 true WO2024050025A3 (en) 2024-04-11

Family

ID=90098616

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2023/031726 Ceased WO2024050025A2 (en) 2022-08-31 2023-08-31 A catheter for hydrodynamic injection

Country Status (2)

Country Link
EP (1) EP4580736A2 (en)
WO (1) WO2024050025A2 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110263974A1 (en) * 1998-05-21 2011-10-27 Of Health And Human Services Method for pressure mediated selective delivery of therapeutic substances and cannula
US20160008017A1 (en) * 2004-04-21 2016-01-14 Acclarent, Inc. Devices, systems and methods for diagnosing and treating sinusitis and other disorders of the ears, nose, and/or throat
US20190314574A1 (en) * 2018-04-13 2019-10-17 Alcyone Lifesciences, Inc. Devices and methods for percutaneous lung intratumoral therapy delivery
US20200345867A1 (en) * 2019-04-30 2020-11-05 The Johns Hopkins University Organ directed gene delivery

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110263974A1 (en) * 1998-05-21 2011-10-27 Of Health And Human Services Method for pressure mediated selective delivery of therapeutic substances and cannula
US20160008017A1 (en) * 2004-04-21 2016-01-14 Acclarent, Inc. Devices, systems and methods for diagnosing and treating sinusitis and other disorders of the ears, nose, and/or throat
US20190314574A1 (en) * 2018-04-13 2019-10-17 Alcyone Lifesciences, Inc. Devices and methods for percutaneous lung intratumoral therapy delivery
US20200345867A1 (en) * 2019-04-30 2020-11-05 The Johns Hopkins University Organ directed gene delivery

Also Published As

Publication number Publication date
WO2024050025A2 (en) 2024-03-07
EP4580736A2 (en) 2025-07-09

Similar Documents

Publication Publication Date Title
Foster et al. Gene-specific control of the TLR-induced inflammatory response
WO2020172343A3 (en) Treatment of liver injury
EP4338662A3 (en) Predictive therapy neurostimulation systems
EP4631571A3 (en) Combination of dextromethorphan and bupropion for treating depression
ATE536154T1 (en) MEDICAL COATING SYSTEM AND COATING PROCESS FOR WIRES
DE69215722D1 (en) Amplifiers for the ultrasound therapy of diseases and liquid pharmaceutical compositions containing them
MX2022002919A (en) Novel class 2 type ii and type v crispr-cas rna-guided endonucleases.
WO2004110380A3 (en) Treatment of immune-mediated disorders with active vitamin d compounds alone or in combination with other therapeutic agents
WO2021041539A3 (en) Pyrido-indole analogues as gpx4 inhibitors
MX2023012875A (en) 2-fluoroalkyl-1,3,4-oxadiazol-5-yl-thiazol, hdac6 inhibitors for use in the treatment of metabolic disease and hfpef.
WO2022216379A8 (en) Combination therapies for the treatment of cancer
MX2022004056A (en) Novel skin care composition.
ATE226094T1 (en) METHOD FOR DELIVERING MEDICINAL MEDICINAL USING GENE THERAPY
Lindsey et al. Pressor effect mediated by bradykinin in the paratrigeminal nucleus of the rat
WO2024050025A3 (en) A catheter for hydrodynamic injection
WO2020068950A8 (en) Hdac1,2 inhibitors
WO2022178255A3 (en) Single domain antibodies that neutralize sars-cov-2
MX2020011453A (en) Combinations for treating cancer.
MX2022004055A (en) Novel skin care composition.
DE60134576D1 (en) DRUGS TO TREAT DARMER DISEASES
WO2008147906A3 (en) Microscopic tumor injection treatment
CA3199014A1 (en) Combination therapy for the treatment of a liver disease
WO2007008899A3 (en) Variable feathering field splitting for intensity modulated fields of large size
NZ515727A (en) Aminotetralin derivative for the therapy of cardiovascular diseases
WO2025038540A3 (en) Brain modulation systems and methods

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 23861304

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2023861304

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2023861304

Country of ref document: EP

Effective date: 20250331

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 23861304

Country of ref document: EP

Kind code of ref document: A2

WWP Wipo information: published in national office

Ref document number: 2023861304

Country of ref document: EP